Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "Number-of-Consecutive-Periods-With-Dividend-Payments" stands at 62.00 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Number of Consecutive Periods With Dividend Payments" stands at 62.00. This represents an increase of 1.64 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.90 percent compared to the value the year prior.
The 1 year change in percent is 6.90.
The 3 year change in percent is 24.00.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Number of Consecutive Periods With Dividend Payments | 905,699,262,464.00 |
![]() | Johnson & Johnson - Number of Consecutive Periods With Dividend Payments | 486,508,953,600.00 |
![]() | AbbVie Inc - Number of Consecutive Periods With Dividend Payments | 399,570,305,024.00 |
![]() | Roche Holding AG - Number of Consecutive Periods With Dividend Payments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Number of Consecutive Periods With Dividend Payments | 280,205,508,085.11 |